Skip to Main content Skip to Navigation
Journal articles

[Therapeutics. New anticoagulants: stop the controversy!].

David M. Smadja 1, 2, * 
* Corresponding author
1 U765 - Risque Thrombotique et Mecanismes de l'Hemostase
2 HEGP - Hôpital Européen Georges Pompidou [APHP]
Mots-clés : anticoagulants nouveaux anticoagulants (NACO NOAC) rivaroxaban dabigatran
Document type :
Journal articles
Complete list of metadata

Cited literature [15 references]  Display  Hide  Download
https://www.hal.inserm.fr/inserm-00916701
Contributor : Smadja David Connect in order to contact the contributor
Submitted on : Tuesday, December 10, 2013 - 3:42:21 PM
Last modification on : Thursday, November 18, 2021 - 3:57:09 AM
Long-term archiving on: : Saturday, April 8, 2017 - 5:46:12 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

  • HAL Id : inserm-00916701, version 1
  • PUBMED : 24298817

Collections

INSERM | IRD | UNIV-PARIS5 | ENSCP | CNRS | IFR71 | PARISTECH | PSL | UNIV-PARIS

Citation

David M. Smadja. [Therapeutics. New anticoagulants: stop the controversy!].. Revue du Praticien (La), J B Bailliere et Fils, 2013, 63 (8), pp.1044-7. ⟨inserm-00916701⟩

Export

BibTeX TEI DC DCterms EndNote Datacite

Share

Metrics

Record views

317